Intravenous Immunoglobulin Market Report 2026
Download Free Sample Buy Now
Intravenous Immunoglobulin Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Intravenous Immunoglobulin Market Report 2026

Global Outlook – By Type (IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels ), By Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications ), By End-User (Hospitals, Clinics, Home Care) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Intravenous Immunoglobulin Market Overview

• Intravenous Immunoglobulin market size has reached to $15.57 billion in 2025

• Expected to grow to $23.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Geriatric Population Fuels Growth In The Intravenous Immunoglobulin Market

• Market Trend: A Breakthrough in Plasma-Derived Immunoglobulin Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intravenous Immunoglobulin Market?

Intravenous immunoglobulin refers to a therapy used for the treatment of immunodeficient people. It is administered in the form of intravenous infusion. Infusion liquid is made from immunoglobulins collected from healthy individuals and purified to eliminate any blood-borne infection or impurity.

The main types of intravenous immunoglobulin are Immunoglobulin G (IgE), Immunoglobulin M (IgM), Immunoglobulin A (IgA), (Immunoglobulin E (IgE), Immunoglobulin D (IgD). Immunoglobulin G refers to the most common immunoglobulin found in blood and other body fluids and defends the body against bacterial and viral infection. IgG is used to boost the body’s natural defense system. These are distributed through hospital pharmacy, retail pharmacy, and others, used in applications such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), primary immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, and others. The various end-users include hospitals, clinics, and home care.

Intravenous Immunoglobulin Market Global Report 2026 Market Report bar graph

What Is The Intravenous Immunoglobulin Market Size and Share 2026?

The intravenous immunoglobulin market size has grown strongly in recent years. It will grow from $15.57 billion in 2025 to $16.86 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of primary immunodeficiency diseases, advancements in immunoglobulin purification techniques, increased hospital-based ivig administration, growing awareness about autoimmune disorders, expansion of ivig production facilities.

What Is The Intravenous Immunoglobulin Market Growth Forecast?

The intravenous immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $23.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for home-based ivig therapy, development of biosimilar ivig products, integration of automated infusion technologies, expanding applications in neurological disorders, growth in emerging markets for immunoglobulin therapies. Major trends in the forecast period include personalized immunoglobulin therapy, home-based ivig administration, biosimilar development and adoption, enhanced purification and safety protocols, automated infusion systems.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Intravenous Immunoglobulin Market Segmentation

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

What Is The Driver Of The Intravenous Immunoglobulin Market?

The increasing geriatric population is expected to drive the intravenous immunoglobulin market forward. The geriatric population refers to the population above 65 years of age. As people grow old, their immunity does not work properly and there is a lack of antibodies. Therefore, they need immunoglobulins to provide them with antibodies. This increases demand for intravenous immunoglobulins and drives the intravenous immunoglobulin market forward. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based Nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. As a result, the increasing geriatric population will drive the growth of the intravenous immunoglobulin industry forward.

Key Players In The Global Intravenous Immunoglobulin Market

Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

Global Intravenous Immunoglobulin Market Trends and Insights

Major companies operating in the intravenous immunoglobin market are focused on introducing innovative products, such as plasma-derived medicines, and getting them approved by federal agencies, including the US FDA, to gain a competitive edge in the market. The introduction of an FDA-approved innovative IVIG solution signifies the approval of a novel intravenous immunoglobulin (IVIG) therapy by the U.S. Food and Drug Administration for the treatment of specific medical conditions. For instance, in June 2024, Biotest AG, a Germany-based supplier of plasma proteins and products company announced its first U.S. Food and Drug Administration (FDA) approval Yimmugo for the treatment of primary immunodeficiencies. As an intravenous immunoglobulin, Yimmugo contains pooled human plasma-derived immunoglobulin G (IgG), which plays a crucial role in immune support for patients with PIDs. The approval comes amid increasing demand for plasma-derived therapies, highlighting the need for effective treatments for patients with compromised immune systems. Yimmugo adds to Grifols' existing range of intravenous and subcutaneous immunoglobulins, providing more options for patients reliant on these essential medicines.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Intravenous Immunoglobulin Market?

In February 2024, Ridgemont Equity Partners, a US-based equity investor company acquired American Outcomes Management for an undisclosed amount. This acquisition aligns with Ridgemont's strategic focus on the growing specialty infusion market, which is driven by an aging population with chronic conditions and a rising demand for at-home treatment options. American Outcomes Management is a US-based provider of intravenous immunoglobulin (IVIG) infusion therapy.

Regional Insights

North America was the largest region in the intravenous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Intravenous Immunoglobulin Market?

The intravenous immunoglobulin market consists of sales of intravenous immunoglobulin used for treating people with antibody deficiencies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intravenous Immunoglobulin Market Report 2026?

The intravenous immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous immunoglobulin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Intravenous Immunoglobulin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $16.86 billion
Revenue Forecast In 2035 $23.44 billion
Growth Rate CAGR of 8.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Distribution Channel, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotec
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Intravenous Immunoglobulin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Intravenous Immunoglobulin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Intravenous Immunoglobulin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Intravenous Immunoglobulin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Autonomous Systems, Robotics & Smart Mobility

4.2. Major Trends

4.2.1 Personalized Immunoglobulin Therapy

4.2.2 Home-Based Ivig Administration

4.2.3 Biosimilar Development And Adoption

4.2.4 Enhanced Purification And Safety Protocols

4.2.5 Automated Infusion Systems

5. Intravenous Immunoglobulin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Care Providers

5.4 Specialty Treatment Centers

5.5 Research Laboratories

6. Intravenous Immunoglobulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravenous Immunoglobulin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Intravenous Immunoglobulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Intravenous Immunoglobulin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Intravenous Immunoglobulin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Intravenous Immunoglobulin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravenous Immunoglobulin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravenous Immunoglobulin Market Segmentation

9.1. Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

9.2. Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

9.3. Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

9.4. Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Care, Specialty Treatment Centers

10. Intravenous Immunoglobulin Market Regional And Country Analysis

10.1. Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravenous Immunoglobulin Market

11.1. Asia-Pacific Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravenous Immunoglobulin Market

12.1. China Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravenous Immunoglobulin Market

13.1. India Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravenous Immunoglobulin Market

14.1. Japan Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravenous Immunoglobulin Market

15.1. Australia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravenous Immunoglobulin Market

16.1. Indonesia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravenous Immunoglobulin Market

17.1. South Korea Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravenous Immunoglobulin Market

18.1. Taiwan Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravenous Immunoglobulin Market

19.1. South East Asia Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravenous Immunoglobulin Market

20.1. Western Europe Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravenous Immunoglobulin Market

21.1. UK Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravenous Immunoglobulin Market

22.1. Germany Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravenous Immunoglobulin Market

23.1. France Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravenous Immunoglobulin Market

24.1. Italy Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravenous Immunoglobulin Market

25.1. Spain Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravenous Immunoglobulin Market

26.1. Eastern Europe Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravenous Immunoglobulin Market

27.1. Russia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravenous Immunoglobulin Market

28.1. North America Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravenous Immunoglobulin Market

29.1. USA Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravenous Immunoglobulin Market

30.1. Canada Intravenous Immunoglobulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravenous Immunoglobulin Market

31.1. South America Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravenous Immunoglobulin Market

32.1. Brazil Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravenous Immunoglobulin Market

33.1. Middle East Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravenous Immunoglobulin Market

34.1. Africa Intravenous Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravenous Immunoglobulin Market Regulatory and Investment Landscape

36. Intravenous Immunoglobulin Market Competitive Landscape And Company Profiles

36.1. Intravenous Immunoglobulin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Intravenous Immunoglobulin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Intravenous Immunoglobulin Market Company Profiles

36.3.1. Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Intravenous Immunoglobulin Market Other Major And Innovative Companies

Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma

38. Global Intravenous Immunoglobulin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market

40. Intravenous Immunoglobulin Market High Potential Countries, Segments and Strategies

40.1 Intravenous Immunoglobulin Market In 2030 - Countries Offering Most New Opportunities

40.2 Intravenous Immunoglobulin Market In 2030 - Segments Offering Most New Opportunities

40.3 Intravenous Immunoglobulin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Intravenous Immunoglobulin Market, Overview Of Key Products - Product Examples
  • Table 2: Global Intravenous Immunoglobulin Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Intravenous Immunoglobulin Market, Supply Chain Analysis
  • Table 4: Global Intravenous Immunoglobulin Market, Major Raw Material Providers
  • Table 5: Global Intravenous Immunoglobulin Market, Major Resource Providers
  • Table 6: Global Intravenous Immunoglobulin Market, Major Manufacturers (Suppliers)
  • Table 7: Global Intravenous Immunoglobulin Market, Major Distributors And Channel Partners
  • Table 8: Global Intravenous Immunoglobulin Market, Key Technologies & Future Trends
  • Table 9: Global Intravenous Immunoglobulin Market, Major Trends
  • Table 10: Global Intravenous Immunoglobulin Market, Major End Users
  • Table 11: Global Intravenous Immunoglobulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Intravenous Immunoglobulin Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Intravenous Immunoglobulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Intravenous Immunoglobulin Market - TAM, US$ Billion, 2025
  • Table 15: Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: UK, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Germany, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: France, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Italy, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Spain, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Russia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: North America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: USA, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Canada, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: South America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Brazil, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Middle East, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Africa, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Global Intravenous Immunoglobulin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 94: Global Intravenous Immunoglobulin Market - Company Scoring Matrix
  • Table 95: Bio Products Laboratory Limited Financial Performance
  • Table 96: Biotest AG Financial Performance
  • Table 97: China Biologic Products Holdings Inc. Financial Performance
  • Table 98: CSL Behring Financial Performance
  • Table 99: Grifols S.A. Financial Performance
  • Table 100: Global Intravenous Immunoglobulin Market, Competitive Benchmarking (In USD Billions)
  • Table 101: Global Intravenous Immunoglobulin Market, Competitive Dashboard
  • Table 102: Global Intravenous Immunoglobulin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 103: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 104: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 105: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Intravenous Immunoglobulin Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Intravenous Immunoglobulin Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Intravenous Immunoglobulin Market, Supply Chain Analysis
  • Figure 4: Global Intravenous Immunoglobulin Market, Major Raw Material Providers
  • Figure 5: Global Intravenous Immunoglobulin Market, Major Resource Providers
  • Figure 6: Global Intravenous Immunoglobulin Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Intravenous Immunoglobulin Market, Major Distributors And Channel Partners
  • Figure 8: Global Intravenous Immunoglobulin Market, Key Technologies & Future Trends
  • Figure 9: Global Intravenous Immunoglobulin Market, Major Trends
  • Figure 10: Global Intravenous Immunoglobulin Market, Major End Users
  • Figure 11: Global Intravenous Immunoglobulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Intravenous Immunoglobulin Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Intravenous Immunoglobulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Intravenous Immunoglobulin Market - TAM, US$ Billion, 2025
  • Figure 15: Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: UK, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Germany, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: France, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Italy, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Spain, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Russia, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: North America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: USA, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Canada, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: South America, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Brazil, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Middle East, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Africa, Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Global Intravenous Immunoglobulin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 94: Global Intravenous Immunoglobulin Market - Company Scoring Matrix
  • Figure 95: Bio Products Laboratory Limited Financial Performance
  • Figure 96: Biotest AG Financial Performance
  • Figure 97: China Biologic Products Holdings Inc. Financial Performance
  • Figure 98: CSL Behring Financial Performance
  • Figure 99: Grifols S.A. Financial Performance
  • Figure 100: Global Intravenous Immunoglobulin Market, Competitive Benchmarking (In USD Billions)
  • Figure 101: Global Intravenous Immunoglobulin Market, Competitive Dashboard
  • Figure 102: Global Intravenous Immunoglobulin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 103: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 104: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 105: Global, Intravenous Immunoglobulin Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Read More About Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Read More About Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Read More About Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Immunoglobulins Market Report 2026 - Global Outlook – By Product (IGG, IGA, IGM, IGE, IGD), By Mode Of Delivery (Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery ), By Application (Hypogammaglobulinemia, Chron...

High-Intensity Artificial Sweeteners Market Report 2026 - Global Outlook – By Type (Saccharin, Acesulfame Potassium, Neotame, Aspartame, Sucralose, Advantame), By Form (Solid, Liquid), By Sales Channel (Direct Sales (B2B...

Foreign Body Removal Market Report 2026 - Global Outlook – By Device Type (Forceps, Retrieval Baskets, Balloon Catheter, Other Device Types), By Application (Stomach, Gut, Mouth, Ear, Nose, Other Applications), By End Us...

Affiliate Software Market Report 2026 - Global Outlook – By Type (On-Premise, Cloud-Based), By Application (Small And Medium Enterprises, Large Enterprises), By End-User (Retailers, Publishers, Advertisers) – Market Size...

DNA Digital Data Storage Market Report 2026 - Global Outlook – By Sequencing (Synthesis, Ion Semiconductor, Chain Termination, Ligation, Nanopore Sequencing), By Deployment (Cloud, On-Premise), By Application (Diagnostic...

Gaskets, Packing, and Sealing Devices Market Report 2026 - Global Outlook – By Product (Gaskets, Seals), By Material Type (Metallic, Non-metallic, Elastomeric, Other Material Types), By Distribution Channel (Original Equ...

Frequently Asked Questions

The Intravenous Immunoglobulin market was valued at $15.57 billion in 2025, increased to $16.86 billion in 2026, and is projected to reach $23.44 billion by 2030.

The global Intravenous Immunoglobulin market is expected to grow at a CAGR of 8.6% from 2026 to 2035 to reach $23.44 billion by 2035.

Some Key Players in the Intravenous Immunoglobulin market Include, Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda

Major trend in this market includes: A Breakthrough in Plasma-Derived Immunoglobulin Therapy. For further insights on this market. request a sample here

North America was the largest region in the intravenous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us